Medical Biotechnology. Profiling China: Markets and Stakeholders
Together with Germany Trade & Invest (GTAI), the Export Initiative for the German Healthcare Industry, HEALTH MADE IN GERMANY, is publishing a study on medical biotechnology in China. In addition to providing an overview of China's medical biotechnology sector, the study provides information on the location of research and production clusters as well as standards for approval of biomedical products, drugs and diagnostic aids. The publication also profiles the four largest medical biotechnology clusters and includes lists of addresses and contacts.
HEALTH MADE IN GERMANY is an initiative of Germany's Federal Ministry for Economic Affairs and Energy (BMWi). Germany's economic development agency GTAI has been commissioned by the BMWi to implement it.
- Recommend this page:
- Print view